Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Aug 17, 2007

Mechanism of Treg Recruitment in Cancer Revealed

  • Cancers cells in animal models use indoleamine 2,3-dioxygenase (IDO), an enzyme used by fetuses to help avoid rejection, to recruit Treg cells that turn down the immune response, report scientists at the Medical College of Georgia Cancer Center.

    The study found that IDO, which seems to play a role in tumor survival despite the relatively few number of cells in the tumor’s draining lymph nodes, directly activates existing Tregs that become strongly suppressive within a day. This rapid conversion occurs only in lymph nodes connected to tumors.

    The researchers also discovered that the Tregs then up-regulate the PD-L1/PD-L2 pathway, which has been shown to play an important role in the immune suppression caused by AIDS.

    The study was published online in the August 16 issue of The Journal of Clinical Investigation.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »